| Dr Trevor Carl Hansen, MD | |
|
1220 George C. Wilson Drive, Augusta, GA 30909 | |
| (706) 941-8206 | |
| Not Available |
| Full Name | Dr Trevor Carl Hansen |
|---|---|
| Gender | Male |
| Speciality | Surgery - Plastic And Reconstructive Surgery |
| Location | 1220 George C. Wilson Drive, Augusta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821450610 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2082S0105X | Plastic Surgery - Surgery Of The Hand | 95333 (Georgia) | Secondary |
| 2086S0122X | Surgery - Plastic And Reconstructive Surgery | 95333 (Georgia) | Primary |
| Entity Name | Augusta Oncology Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912917824 PECOS PAC ID: 8921089756 Enrollment ID: O20040527000702 |
News Archive
A team of researchers at CNRS, Aix-Marseille Université and Université Paris 13 has demonstrated effective molecular labeling to unequivocally identify biomedical implants, even after a prolonged period inside the living being. These results were published in Angewandte Chemie International Edition on July 5, 2018.
FASgen Inc.'s compound, FAS20013, has emerged from an intense multi-year program of pre-clinical studies that clearly validate its potential as an ideal new drug for the treatment of tuberculosis and MDR-TB, the disease caused by organisms that are resistant to the drugs now commonly used to treat TB. Initial clinical trials in both TB and MDR-TB are scheduled for later this year.
Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy (ART) for head and neck cancer.
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
The research teams headed by Prof. Johanna Ivaska (University of Turku and VTT Technical Research Centre of Finland) and Prof. Marko Salmi (University of Turku and the National Institute for Health and Welfare) have discovered that the SHARPIN protein regulates human cell activity.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Trevor Carl Hansen, MD 3696 Wheeler Rd, Augusta, GA 30909-6520 Ph: (706) 736-1830 | Dr Trevor Carl Hansen, MD 1220 George C. Wilson Drive, Augusta, GA 30909 Ph: (706) 941-8206 |
News Archive
A team of researchers at CNRS, Aix-Marseille Université and Université Paris 13 has demonstrated effective molecular labeling to unequivocally identify biomedical implants, even after a prolonged period inside the living being. These results were published in Angewandte Chemie International Edition on July 5, 2018.
FASgen Inc.'s compound, FAS20013, has emerged from an intense multi-year program of pre-clinical studies that clearly validate its potential as an ideal new drug for the treatment of tuberculosis and MDR-TB, the disease caused by organisms that are resistant to the drugs now commonly used to treat TB. Initial clinical trials in both TB and MDR-TB are scheduled for later this year.
Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy (ART) for head and neck cancer.
Human Genome Sciences, Inc. announced today that several abstracts related to BENLYSTA (belimumab) and systemic lupus erythematosus will be presented at the annual meeting of the American College of Rheumatology/ Association of Rheumatology Health Professionals, being held in Chicago, IL from November 4 to November 9, 2011.
The research teams headed by Prof. Johanna Ivaska (University of Turku and VTT Technical Research Centre of Finland) and Prof. Marko Salmi (University of Turku and the National Institute for Health and Welfare) have discovered that the SHARPIN protein regulates human cell activity.
› Verified 5 days ago
Dr. Erika Simmerman Mabes, D.O. Surgery Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-3052 Fax: 706-721-7501 | |
Dr. Elizabeth D Fox, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-8623 Fax: 706-721-1459 | |
Mary Kathryn Boggs, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 3647 J Dewey Gray Cir Ste 200, Augusta, GA 30909 Phone: 706-504-9712 Fax: 706-504-9703 | |
Dr. James Raley, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-2503 Fax: 706-721-1047 | |
Dr. Kathryne Holmes, MD Surgery Medicare: Medicare Enrolled Practice Location: 1120 15th St Rm Bi4076, Augusta, GA 30912 Phone: 706-721-4651 | |
Mr. Keith F. O'malley, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 1120 15th St, Augusta, GA 30912 Phone: 706-721-3671 | |
Dr. Thuy-huong Thi Pham, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1120 15th St, Bl 4070, Augusta, GA 30912 Phone: 706-721-0000 Fax: 706-721-1047 |